Pandemic Perspectives: COVID-19 Upended Drug Launches In Ways That Will Stick
Hybrid Commercial Models Are Here To Stay
Preliminary data from IQVIA suggest 2020 was one of the weakest in recent years for new launch trajectories although drug companies tell Scrip there are some lessons learned from promoting during the pandemic.
